EUCTR2015-005287-41-DE进行中（未招募）1 期
A randomized, double-blind trial of single doses of ZP4207 administered s.c. to hypoglycemic Type 1 diabetic patients to describe the pharmacokinetics and pharmacodynamics of ZP4207 as compared to marketed glucagon
Zealand Pharma A/S0 个研究点开始时间: 2015年12月22日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Male and female patients with T1D for at least one year, as defined by the American Diabetes Association
- •Having been treated with insulin for T1D for at least 1 year.
- •Age between 18 and 50 years, both inclusive.
- •Body weight between 60 and 90 kg, both inclusive
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 56
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Previously treated with ZP4207.
- •Known or suspected allergy to trial product(s) or related products.
- •Previous participation (randomization) in this trial.
研究者
相似试验
已完成
1 期
A randomised, double-blind, single-dose study to evaluate the pharmacokinetic, safety, tolerability, immunogenicity and pharmacodynamic profile of ISU305 compared to Soliris® (Eculizumab) in Healthy Male VolunteersParoxysmal nocturnal haemoglobinuria (PNH)Atypical haemolytic uraemic syndrome (aHUS)Inflammatory and Immune System - Other inflammatory or immune system disordersBlood - AnaemiaRenal and Urogenital - Other renal and urogenital disordersACTRN12619000694112ISU Abxis148
已完成
不适用
A Randomized, Double Blind, Single Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of ONS-3010 (Adalimumab, Oncobiologics, Inc.) Compared to Two Reference Products of Humira® (Abbvie) in Healthy Adult SubjectsAutoimmune disease10003816NL-OMON41013Oncobiologics Inc.180
尚未招募
不适用
A comparative pharmacokinetic study of AryoGen Pharmedâ??s AryoTrust (Trastuzumab) and â??HERCEPTINâ?? (Trastuzumab) in healthy, adult, male subjectsCTRI/2019/03/018218AryoGen Pharmed
尚未招募
1 期
Pharmacokinetic study of ZRC-3113 (Zydus Bevacizumab) and â??Avastinâ?¢â?? (Bevacizumab) in Healthy, Adult, Male subjectsCTRI/2020/01/022946Cadila Healthcare Ltd
已完成
不适用
A study comparing the blood levels of two trastuzumab formulations given as a single dose in healthy adult males.breast cancerACTRN12616000084482Dr Reddy's laboratories (Australia) Pty Ltd32